Wound Care (Pharmacies) - Israel | Statista Market Forecast

Revenue in the Wound Care market is projected to reach US$3.35m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.99%, resulting in a market volume of US$3.52m by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$0.36 are generated in 2024.

Definition:
The Wound Care market consists of a comprehensive array of over-the-counter (OTC) solutions available for purchase through pharmacies. These solutions are aimed at managing wounds, promoting healing, and preventing infections. The product offerings encompass adhesive bandages for minor wound coverage, first aid kits providing extensive supplies, gauze and tape for maintaining cleanliness, as well as wound healing ointments that support the recovery of damaged skin and wounds. This market exclusively covers product sales through pharmacies.

Additional information:
The Wound Care market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Plasters
Adhesive Bandages
First Aid Kits
Gauze
Healing Ointment

Anti-Foot Blister Products
Wound Closure Devices, which require professional application
Prescription Wound Treatments

The Wound Care (Pharmacies) market in Israel has been experiencing significant growth in recent years. Customer preferences for wound care products have shifted towards more advanced and innovative solutions, driving the demand for these products in the market. Additionally, local special circumstances and underlying macroeconomic factors have also contributed to the development of the market. Customer preferences in the Wound Care (Pharmacies) market in Israel have been influenced by the growing awareness of the importance of wound care and the availability of a wide range of products. Customers are increasingly seeking products that are not only effective in treating wounds but also provide faster healing and better comfort. This has led to a rise in demand for advanced wound care products, such as hydrocolloid dressings and foam dressings, which offer superior wound healing properties. Customers are also looking for products that are easy to use and convenient, such as adhesive bandages and wound closure strips. The market has also witnessed a trend towards the use of wound care products with antimicrobial properties. This is driven by the increasing concern over infections and the need for effective infection control measures. Antimicrobial wound care products, such as silver dressings and antimicrobial gels, have gained popularity among customers as they help prevent infections and promote faster healing. Local special circumstances in Israel have contributed to the growth of the Wound Care (Pharmacies) market. Israel has a high prevalence of chronic wounds, such as diabetic foot ulcers, which require specialized wound care treatment. The country also has a rapidly aging population, which is more prone to developing chronic wounds. These factors have created a significant demand for wound care products in the market. Underlying macroeconomic factors have also played a role in the development of the market. Israel has a strong healthcare system and a high level of healthcare expenditure, which has facilitated the availability and accessibility of wound care products in pharmacies. The government has also implemented policies to promote the use of advanced wound care products and improve the quality of wound care services, further driving the growth of the market. In conclusion, the Wound Care (Pharmacies) market in Israel is experiencing growth due to customer preferences for advanced and innovative wound care products, the presence of local special circumstances such as a high prevalence of chronic wounds, and underlying macroeconomic factors such as a strong healthcare system and government policies. This trend is expected to continue as the demand for effective wound care solutions continues to rise.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.